147 related articles for article (PubMed ID: 26662347)
1. Hepatitis C viral infection increases the risk of lymphoid-neoplasms: A population-based cohort study.
Su TH; Liu CJ; Tseng TC; Chou SW; Liu CH; Yang HC; Wu SJ; Chen PJ; Chen DS; Chen CL; Kao JH
Hepatology; 2016 Mar; 63(3):721-30. PubMed ID: 26662347
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B and C virus infection and risk of lymphoid malignancies: A population-based cohort study (JPHC Study).
Abe SK; Inoue M; Sawada N; Iwasaki M; Shimazu T; Yamaji T; Sasazuki S; Tanaka Y; Mizokami M; Tsugane S;
Cancer Epidemiol; 2015 Aug; 39(4):562-6. PubMed ID: 26149122
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: a meta-analysis of epidemiologic studies.
Dal Maso L; Franceschi S
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2078-85. PubMed ID: 17119031
[TBL] [Abstract][Full Text] [Related]
4. Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myeloma.
Su TH; Liu CJ; Tseng TC; Chou SW; Liu CH; Yang HC; Wu SJ; Chen PJ; Chen DS; Chen CL; Kao JH
Aliment Pharmacol Ther; 2019 Mar; 49(5):589-598. PubMed ID: 30681172
[TBL] [Abstract][Full Text] [Related]
5. Chronic hepatitis infection is associated with extrahepatic cancer development: a nationwide population-based study in Taiwan.
Kamiza AB; Su FH; Wang WC; Sung FC; Chang SN; Yeh CC
BMC Cancer; 2016 Nov; 16(1):861. PubMed ID: 27821099
[TBL] [Abstract][Full Text] [Related]
6. Add-on neurological benefits of antiviral therapy in HCV patients with chronic kidney disease - a nationwide cohort study.
Lin MS; Chen TH; Lin WY; Liu CH; Hsieh YY; Chiu WN; Chang CH; Chen MY; Chung CM; Lin YS
BMC Gastroenterol; 2017 Aug; 17(1):99. PubMed ID: 28814273
[TBL] [Abstract][Full Text] [Related]
7. Liver cancer and non-Hodgkin lymphoma in hepatitis C virus-infected patients: results from the DANVIR cohort study.
Omland LH; Jepsen P; Krarup H; Christensen PB; Weis N; Nielsen L; Obel N; Sørensen HT; Stuver SO;
Int J Cancer; 2012 May; 130(10):2310-7. PubMed ID: 21780099
[TBL] [Abstract][Full Text] [Related]
8. A nationwide cohort study suggests that hepatitis C virus infection is associated with increased risk of chronic kidney disease.
Chen YC; Lin HY; Li CY; Lee MS; Su YC
Kidney Int; 2014 May; 85(5):1200-7. PubMed ID: 24257691
[TBL] [Abstract][Full Text] [Related]
9. Antiviral therapy reduces risk of haemorrhagic stroke in patients with HCV infection: a nationwide cohort study.
Lin MS; Chung CM; Lin WY; Wei KL; Wang J; Lee YY; Hu JH; Tung TH; Lin YS
Antivir Ther; 2018; 23(1):43-52. PubMed ID: 28471350
[TBL] [Abstract][Full Text] [Related]
10. Increasing risk of cataract in HCV patients receiving anti-HCV therapy: A nationwide cohort study.
Lin SY; Lin CL; Ju SW; Wang IK; Lin CC; Lin CH; Hsu WH; Liang JA
PLoS One; 2017; 12(3):e0173125. PubMed ID: 28264004
[TBL] [Abstract][Full Text] [Related]
11. Non-Hodgkin's lymphoma and other nonhepatic malignancies in Swedish patients with hepatitis C virus infection.
Duberg AS; Nordström M; Törner A; Reichard O; Strauss R; Janzon R; Bäck E; Ekdahl K
Hepatology; 2005 Mar; 41(3):652-9. PubMed ID: 15723449
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus infection increases the risk of developing peripheral arterial disease: a 9-year population-based cohort study.
Hsu YH; Muo CH; Liu CY; Tsai WC; Hsu CC; Sung FC; Kao CH
J Hepatol; 2015 Mar; 62(3):519-25. PubMed ID: 25263004
[TBL] [Abstract][Full Text] [Related]
13. Incidence of non-Hodgkin's lymphoma among individuals with chronic hepatitis B virus infection.
Ulcickas Yood M; Quesenberry CP; Guo D; Caldwell C; Wells K; Shan J; Sanders L; Skovron ML; Iloeje U; Manos MM
Hepatology; 2007 Jul; 46(1):107-12. PubMed ID: 17526021
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus infection and risk of intrahepatic cholangiocarcinoma and non-Hodgkin lymphoma: a cohort study of parous women in Taiwan.
Fwu CW; Chien YC; You SL; Nelson KE; Kirk GD; Kuo HS; Feinleib M; Chen CJ
Hepatology; 2011 Apr; 53(4):1217-25. PubMed ID: 21480326
[TBL] [Abstract][Full Text] [Related]
15. Statin use and the risk of cirrhosis development in patients with hepatitis C virus infection.
Yang YH; Chen WC; Tsan YT; Chen MJ; Shih WT; Tsai YH; Chen PC
J Hepatol; 2015 Nov; 63(5):1111-7. PubMed ID: 26196278
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C viral infection and the risk of dementia.
Chiu WC; Tsan YT; Tsai SL; Chang CJ; Wang JD; Chen PC;
Eur J Neurol; 2014 Aug; 21(8):1068-e59. PubMed ID: 24313931
[TBL] [Abstract][Full Text] [Related]
17. Positive association between hepatitis C infection and oral cavity cancer: a nationwide population-based cohort study in Taiwan.
Su FH; Chang SN; Chen PC; Sung FC; Huang SF; Chiou HY; Su CT; Lin CC; Yeh CC
PLoS One; 2012; 7(10):e48109. PubMed ID: 23133554
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study.
Bianco E; Marcucci F; Mele A; Musto P; Cotichini R; Sanpaolo MG; Iannitto E; De Renzo A; Martino B; Specchia G; Montanaro M; Barbui AM; Nieddu R; Pagano L; Rapicetta M; Franceschi S; Mandelli F; Pulsoni A;
Haematologica; 2004 Jan; 89(1):70-6. PubMed ID: 14754608
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus infection as a risk factor for Parkinson disease: A nationwide cohort study.
Tsai HH; Liou HH; Muo CH; Lee CZ; Yen RF; Kao CH
Neurology; 2016 Mar; 86(9):840-6. PubMed ID: 26701382
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus infection and B-cell non-Hodgkin's lymphoma: a cross-sectional study in Lyon, France.
Sève P; Renaudier P; Sasco AJ; Dumontet C; Salles G; Coiffier B; Zoulim F; Broussolle C; Trépo C
Eur J Gastroenterol Hepatol; 2004 Nov; 16(12):1361-5. PubMed ID: 15618846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
